Internal Medicine, Infectious Disease · Monterey, CA
NPI
1619933157
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2 Upper Ragsdale Dr Bldg A
Monterey, CA, 93940
Phone (831) 333-3040
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
2,202 services
Medicare patients, 2024
507
Average age 76
Drug cost, 2024
$3.1M
3,805 prescriptions
Company payments, 2025
$56.1
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David W Keller III was code 11042 (debridement), 409 times for 121 patients. In total David W Keller III billed 2,202 services in 44 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 11042 Debridement | Facility | 409 | 121 | $49.03 | $20K |
| 99214 Office E&M - Established | Office | 335 | 184 | $100.58 | $34K |
| 99213 Office E&M - Established | Office | 205 | 130 | $73.31 | $15K |
| 99213 Office E&M - Established | Facility | 199 | 82 | $52.65 | $10K |
| 99212 Office E&M - Established | Facility | 179 | 78 | $27.85 | $4,986 |
| 11045 Debridement | Facility | 178 | 29 | $19.94 | $3,548 |
| 99183 Hyperbaric Oxygen | Facility | 90 | 16 | $84.49 | $7,604 |
| 99204 Office E&M - New | Office | 79 | 79 | $139.21 | $11K |
| 99203 Office E&M - New | Facility | 77 | 77 | $59.35 | $4,570 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 68 | 45 | $13.36 | $909 |
| 99215 Office E&M - Established | Office | 43 | 36 | $144.82 | $6,227 |
| 99212 Office E&M - Established | Office | 39 | 19 | $45.37 | $1,769 |
| 99203 Office E&M - New | Office | 28 | 28 | $84.31 | $2,361 |
| G0009 Administration of pneumococcal vaccine | Office | 21 | 21 | $34.31 | $721 |
| 90677 Vaccine Product | Office | 21 | 21 | $291.20 | $6,115 |
By year: 2022 $103K for 1,372 services; 2023 $122K for 1,643 services; 2024 $146K for 2,202 services.
Medicare prescription drug claims, 2024
In 2024, the drug David W Keller III prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 225 prescriptions and refills. In total David W Keller III wrote 3,805 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 225 | 227 | 25 | $913K |
| Methenamine Hippurate Generic | 191 | 308 | 52 | $14K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 158 | 166 | 15 | $639K |
| Lorazepam Generic | 106 | 114 | 13 | $1,015 |
| Atorvastatin Calcium Generic | 99 | 181 | 18 | $1,071 |
| Amlodipine Besylate Generic | 89 | 163 | 17 | $738 |
| Gabapentin Generic | 83 | 90 | 13 | $1,399 |
| Fluconazole Generic | 80 | 87 | 24 | $2,165 |
| Doxycycline Hyclate Generic | 73 | 76 | 28 | $1,393 |
| Zolpidem Tartrate Generic | 65 | 74 | Under 11 | $131 |
| Valacyclovir Valacyclovir Hcl | 63 | 77 | 12 | $2,041 |
| Cephalexin Generic | 63 | 85 | 11 | $991 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 61 | 61 | 11 | $1,738 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 60 | 68 | Under 11 | $244K |
| Rosuvastatin Calcium Generic | 57 | 109 | 11 | $593 |
Brand drugs: - claims; generic drugs: 2,953 claims; opioid claims: 115.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David W Keller III $56.1 ($56.1 in general payments such as food, travel and fees) from 1 company. The largest payer was Smith+Nephew, Inc. with $56.1.
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. SNN | 3 | $56.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.